posters Archives | HUB Organoids

Organoid co-cultures with autologous T cells to assess toxicity and efficacy of bispecific antibodies

January 16, 2023

Organoid co-cultures with autologous T cells to assess toxicity and efficacy of bispecific antibodies

Autologous organoids and T cell co-cultures as a powerful personalized platform for immunotherapy

January 16, 2023

Autologous organoids and T cell co-cultures as a powerful personalized platform for immunotherapy

Patient-derived organoids as a relevant tool for preclinical IBD research and drug development

January 16, 2023

Patient-derived organoids as a relevant tool for preclinical IBD research and drug development

Autologous organoids and T cell co-cultures as a powerful personalized platform for immunotherapy

January 16, 2023

Autologous organoids and T cell co-cultures as a powerful personalized platform for immunotherapy

Developing a patient-derived bladder cancer organoid biobank suitable for large-scale drug screenings

January 16, 2023

Developing a patient-derived bladder cancer organoid biobank suitable for large-scale drug screenings

Development of a medium-to-high throughput organoid and bacteria co-culture platform for the assessment of host-pathogen interaction

January 16, 2023

Development of a medium-to-high throughput organoid and bacteria co-culture platform for the assessment of host-pathogen interaction

Patient-derived organoids predict clinical response: a patient in the lab

January 16, 2023

Patient-derived organoids predict clinical response: a patient in the lab

Human liver patient-derived HUB Organoids as a promising tool to study drug-induced liver injury and drug metabolism for improved preclinical toxicology assessment

October 6, 2022

Human liver patient-derived HUB Organoids as a promising tool to study drug-induced liver injury and drug metabolism for improved preclinical toxicology assessment

Patient-derived organoids as a model for treatment diagnosis in Cystic Fibrosis – combinatory treatment with read-through agent, correctors and potentiator on rare mutations

July 6, 2022

Patient-derived organoids as a model for treatment diagnosis in Cystic Fibrosis – combinatory treatment with read-through agent, correctors and potentiator on rare mutations

Patient in the lab: predicting clinical responses using patient-derived organoid screening

June 3, 2022

Patient in the lab: predicting clinical responses using patient-derived organoid screening